Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth
SAN ANTONIO, Aug. 9, 2022 /PRNewswire/ -- Frost & Sullivan Institute is proud to present Samsung Biologics with the 2022 Enlightened Growth Leadership Award. The Institute believes that all organizations must either create or become part of a solution that addresses threats to humanity. Samsung Biologics has not only demonstrated growth excellence through its strong financial performance in 2021, but also excels as a socially responsible enterprise with a concerted focus on the company's strong ESG and sustainability initiatives.
- SAN ANTONIO, Aug. 9, 2022 /PRNewswire/ -- Frost & Sullivan Institute is proud to present Samsung Biologics with the 2022 Enlightened Growth Leadership Award.
- As a response to climate change, Samsung Biologics made progress in reducing Scope 1 and 2 emissions by 32.3% compared to the previous year.
- Frost & Sullivan Institute evaluates nominees on key best practices criteria such as Innovating to Zero, Growth Excellence, and so on.
- Samsung Biologics, along with other recipients of the Enlightened Growth Leadership Best Practices Recognition, will be awarded and celebrated at our virtual banquet on 22ndNovember 2022.